Frontlight ResearchEarly access
Schizophrenia trials in Egypt
1 of 1 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEmpagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients
- Where
- Tanta
- Age
- 18 years to 65 years
- People
- 40
- Run by
- Tanta University
See details and how to joinNCT05669742